| Literature DB >> 35549895 |
Guillaume Bernas1, Mariette Ouellet1, Andréa Barrios1, Hélène Jamann1,2, Catherine Larochelle1,2, Émile Lévy3,4,5, Jean-François Schmouth6,7.
Abstract
BACKGROUND: The discovery of the CRISPR-Cas9 system and its applicability in mammalian embryos has revolutionized the way we generate genetically engineered animal models. To date, models harbouring conditional alleles (i.e. two loxP sites flanking an exon or a critical DNA sequence of interest) are amongst the most widely requested project type that are challenging to generate as they require simultaneous cleavage of the genome using two guides in order to properly integrate the repair template. An approach, using embryo sequential electroporation has been reported in the literature to successfully introduce loxP sites on the same allele. Here, we describe a modification of this sequential electroporation procedure that demonstrated the production of conditional allele mouse models for eight different genes via one of two possible strategies: either by consecutive sequential electroporation (strategy A) or non-consecutive sequential electroporation (strategy B). This latest strategy originated from using the by-product produced when using consecutive sequential electroporation (i.e. mice with a single targeted loxP site) to complete the project.Entities:
Keywords: CRISPR; Conditional; Electroporation; Zygotes; loxP
Mesh:
Year: 2022 PMID: 35549895 PMCID: PMC9097428 DOI: 10.1186/s12896-022-00744-8
Source DB: PubMed Journal: BMC Biotechnol ISSN: 1472-6750 Impact factor: 3.329
Details of the conditional allele targeting projects
| Gene name | Strain | Targeted exons | Distance between both | Limitations | Plan used for project completion |
|---|---|---|---|---|---|
| C57BL/6J | 4 to 7 | 2926 | Distance between both | Strategy A | |
| C57BL/6J | 2 | 522 | Sequence complexity*** | Strategy A | |
| C57BL/6N | 2 | 608 | None | Strategy A | |
| C57BL/6J | 2 | 617 | None | Strategy B | |
| C57BL/6J | 2 | 543 | None | Strategy B | |
| C57BL/6J | 1 | 1463–1492 | Sequence complexity*** | Strategy B | |
| C57BL/6N | 3 | 2509 | Distance between both | Strategy B | |
| C57BL/6J | 6 | 1000 | None | Strategy B |
*Pups properly targeted with loxP sites in the up position from two different guides
**Megamer, IDT
***Megamer could not be synthesized
Fig. 1Decision tree highlighting the different options leading to successful conditional allele generation. A decision tree representing the different options leading to successful conditional allele generation is represented. The project success is based on two different scenarios depending on the initial electroporation outcomes, either by consecutive sequential electroporation (Strategy A) or non-consecutive sequential electroporation (Strategy B)
Details of the results obtained for the Icam1 project using two different reagent concentrations
| Gene name | Procedure | Reagent concentration (per session, μM) | Number of embryos electroporated | Number of embryos implanted | Number of surgeries | Number of gestations | Number of pups born | Percentage of live born animals (%)* |
|---|---|---|---|---|---|---|---|---|
| Consecutive sequential electroporation | 4:4:10 | 100 | 86 | 4 | 3 | 3 | 3 | |
| Consecutive sequential electroporation | 2:2:5 | 100 | 81 | 4 | 4 | 18 | 22 |
*Calculated by dividing the number of pups born by the number of implanted embryos
Fig. 2Consecutive sequential electroporation was successfully applied to generate Icam1 floxed animals. Schematic representation highlighting the primer positions and genotyping strategy used for characterization of Icam1 floxed F0 animals. PCR results from primers 2–5 combination are depicted in the upper middle panel. PCR results and sequencing alignment from primers 1–5 combination are depicted in the lower left panel. PCR results and sequencing alignment from primers 2–6 combination are depicted in the lower right panel. Primers used for sequencing are highlighted in red. The same strategy was applied to complete a total of three different projects (Icam1, Lox, Sar1b)
Details of the projects successfully completed using the consecutive sequential electroporation procedure
| Gene name | Procedure | Number of embryos electroporated | Number of embryos implanted | Number of surgeries | Number of gestations | Number of pups born | Percentage of live born animals (%)* | Number of pups properly targeted | Targeting efficiency (%)** |
|---|---|---|---|---|---|---|---|---|---|
| Consecutive sequential electroporation | 309 | 252 | 10 | 7 | 24 | 10 | 2 | 8 | |
| Consecutive sequential electroporation | 159 | 140 | 5 | 4 | 22 | 16 | 1 | 5 | |
| Consecutive sequential electroporation | 196 | 128 | 5 | 2 | 8 | 6 | 1 | 13 |
*Calculated by dividing the number of pups born by the number of implanted embryos
**Calculated by dividing the number of properly targeted pups by the total number of pups born
Fig. 3Non-consecutive sequential electroporation was successfully applied to generate Clcf1 floxed animals. A Schematic representation highlighting the primer positions and genotyping strategy used for characterization of Clcf1 F0 animals. PCR results from primers 2–6 combination are depicted in the upper-right panel. The sequencing results using primers 3 and 6 are highlighted below. PCR results from primers 1–7 combination are depicted in the lower panel. The sequencing results using primer 1 are highlighted below. B Schematic representation highlighting the primer positions and genotyping strategy used for characterization of Clcf1 floxed F0 animals. PCR results from primers 2–5 combination are depicted in the upper middle panel. PCR results and sequencing alignment from primers 1–5 combination are depicted in the lower left panel. PCR results and sequencing alignment from primers 2–6 combination are depicted in the lower right panel. Primers used for sequencing are highlighted in red. The same strategy was applied to complete a total of four different projects (Loxl1, Pard6a, Clcf1, Mapkap5)
Details of the projects successfully completed using the non-consecutive sequential electroporation procedure
| Gene name | Procedure | Number of embryos electroporated | Number of embryos implanted | Number of surgeries | Number of gestations | Number of pups born | Percentage of live born animal (%)* | Number of pups properly targeted | Targeting efficiency (%)** | |
|---|---|---|---|---|---|---|---|---|---|---|
| Non-consecutive sequential electroporation | 1st | 393 | 305 | 13 | 10 | 26 | 9 | 2 | 8 | |
| 2nd | 264 | 227 | 9 | 6 | 34 | 15 | 1 | 3 | ||
| 2nd | 136 | 132 | 6 | 3 | 17 | 13 | 1 | 6 | ||
| Non-consecutive sequential electroporation | 1st | 210 | 107 | 4 | 4 | 9 | 8 | 1 | 11 | |
| 2nd | 147 | 114 | 5 | 5 | 30 | 26 | 4 | 13 | ||
| Non-consecutive sequential electroporation | 1st | 212 | 173 | 7 | 7 | 26 | 15 | 2 | 8 | |
| 2nd | 180 | 146 | 6 | 4 | 21 | 14 | 5 | 24 | ||
| Non-consecutive sequential electroporation | 1st | 102 | 80 | 3 | 2 | 8 | 10 | 2 | 25 | |
| 2nd | 243 | 196 | 7 | 3 | 24 | 12 | 3 | 13 | ||
| Non-consecutive sequential electroporation | 1st | 165 | 138 | 6 | 5 | 17 | 12 | 1 | 6 | |
| 2nd | 159 | 145 | 7 | 6 | 36 | 25 | 3 | 8 |
*Calculated by dividing the number of pups born by the number of implanted embryos
**Calculated by dividing the number of properly targeted pups by the total number of pups born
Details of the 1-cell or 2-cells targeting rate for each individual project
| Gene name | Procedure | Number of pups born | Number of pups with a | Targeting frequency at the 1-cell stage (%)* | Number of pups with a | Targeting frequency at the 2-cells stage (%)* | Deletion between exon(s)** |
|---|---|---|---|---|---|---|---|
| Consecutive sequential electroporation | 24 | 7 | 29 | 6 | 25 | NA | |
| Consecutive sequential electroporation | 22 | 3 | 14 | 10 | 45 | NA | |
| Consecutive sequential electroporation | 8 | 3 | 38 | 2 | 25 | NA | |
| Non-consecutive sequential electroporation | 26 | 1 | 4 | 5 | 19 | 3 | |
| Non-consecutive sequential electroporation | 9 | 3 | 33 | 0 | 0 | 1 | |
| Non-consecutive sequential electroporation | 26 | 9 | 35 | 1 | 4 | NA | |
| Non-consecutive sequential electroporation | 8 | 3 | 38 | 0 | 0 | NA | |
| Non-consecutive sequential electroporation | 17 | 2 | 12 | 2 | 12 | 4 |
*Calculated by dividing the number of properly targeted pups by the total number of pups born
**Estimate only, based on various PCR combinations